White paper

Key considerations in the safety evaluation of drugs targeting immune checkpoints

Lee Coney, Mandy Horn

Stream the ‘Key considerations in the safety evaluation of drugs targeting immune checkpoints’ webinar today and learn:

  • What is cancer immunotherapy?
  • What are the potential challenges in the safety assessment of antibodies targeting immune system checkpoints?
  • Things to consider when designing and running your nonclinical safety programmes for immune checkpoint targets
  • How to measure immunotoxicity / immunopharmacology
  • What if your chosen therapeutic has no pharmacologically relevant non-clinical safety species?

Register for our webinar on-demand!